Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: no interventional study.
- Who it may be relevant to
- Registry conditions: Acute Hidrosadenitis. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Our primary objective with this cohort will be to define the different phenotypes of acute hidrosadenitis, the characterization of which is essential to define suitable therapeutic approaches. Indeed, our recent data allow us to note that there would be different phenotypes of acute hidrosadenitis and therefore different pathologies inducing different follow-ups and care.
Interventions
- Other no interventional study
no interventional study
Primary outcome measures
- Description of the natural history and identification of the different clinical forms of acute hidrosadenitis [Time frame: through study completion, an average of 3 years]
- Prevalence of severe forms (grade II, III) [Time frame: through study completion, an average of 3 years]
- Definition of different phenotypes of acute hidrosadenitis [Time frame: through study completion, an average of 3 years]
- Identify the environmental factors associated with the chronicity of the disease [Time frame: through study completion, an average of 3 years]
- Identify the environmental factors associated with the chronicity of the disease [Time frame: through study completion, an average of 3 years]
- Identify the environmental factors associated with the chronicity of the disease [Time frame: through study completion, an average of 3 years]
- Identify the environmental factors associated with the chronicity of the disease [Time frame: through study completion, an average of 3 years]
- Identify the environmental factors associated with the chronicity of the disease [Time frame: through study completion, an average of 3 years]
Eligibility criteria
Inclusion criteria
- Patient diagnosed with acute hidrosadenitis by a dermatologist
- Patient agreeing to be part of the study
Exclusion criteria
- Major under guardianship
- Protected persons
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 13 centers
- CHU Angers — Angers
- Chru Brest — Brest
- CHD Vendée — La Roche-sur-Yon
- CH La Rochelle — La Rochelle
- CH — Le Mans
- CH bretagne sud — Lorient
- CHU de Nantes - Dermatologie — Nantes
- Chr D'Orléans — Orléans
- … and 5 more centers
Identifiers
NCT: NCT04352036 · RC19_0418